John Mascarenhas
12 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Revumenib in Patients With Myelofibrosis (NCT07734077) | John Mascarenhas | 2026-12-01 |
| Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias (NCT07447817) | John Mascarenhas | 2026-05-04 |
| Study of Canakinumab in Patients With Myelofibrosis (NCT05467800) | John Mascarenhas | 2022-08-02 |
| Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase Myeloproliferative Neoplasm or Chronic-phase Myelofibrosis With an IDH2 Mutation (NCT04281498) | John Mascarenhas | 2021-01-14 |
| MPN-RC 118 AVID200 in Myelofibrosis (NCT03895112) | John Mascarenhas | 2019-02-15 |
Track John Mascarenhas automatically
Every clearance here is in the API, with alerts when new ones post.